Research paperOphthalmology
Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase 3 SatraGO-1 and SatraGO-2 Randomized Trials.
Published in Ophthalmology. Briceño CA, Idowu OO, Khong JJ et al.
Why it matters
Read the study for its methods, population and findings. The study design is shown above to help you assess its relevance to your practice.
Keep in mind
Interpret the results in the context of the full methods, comparators and study limitations.
References (1)
Source date: 7 Sept 2026 · International